Cephalexin Anhydrous

Cephalexin Anhydrous

SCHEMBL6663551

CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(N)c3ccccc3)[C@@H]2SC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Cephalexin Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 1.00
MAPT P10636 7/20 1.00
ALDH1A1 P00352 6/20 1.00
KMT2A Q03164 5/20 1.00
CYP3A4 P08684 4/20 1.00
SLC15A2 Q16348 3/20 1.00
HPGD P15428 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
BLM P54132 2/20 1.00
CYP2C19 P33261 2/20 1.00
MAPK1 P28482 2/20 1.00
ADRA1A P35348 1/20 1.00
HTR2B P41595 1/20 1.00
MEN1 O00255 4/20 0.85
LMNA P02545 2/20 0.85
ESR1 P03372 1/20 0.85
SLC22A6 Q4U2R8 1/20 0.85
SLC22A8 Q8TCC7 1/20 0.85
KDM4E B2RXH2 6/20 0.77
CYP2C9 P11712 2/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cephalexin Anhydrous SCHEMBL8467348 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL12961263 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL11985597 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL11579781 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL10713860 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL2224252 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL6663545 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL2961 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL20703090 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4
Cephalexin Anhydrous SCHEMBL11569012 1.00 HSD17B10 (1.00) HSD17B10MAPTALDH1A1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908929-A Process for the manufacture of the antibiotic 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid (cephalexin) and pharmaceutically acceptable salts thereof VITARA CHEMICALS LIMITED (IN) 1999-06-01 US claimed
EP-0038626-A1 A process for electrolytic reduction of cephalosporin p-nitrobenzyl esters ELI LILLY AND COMPANY (US) 1981-10-28 EP claimed
US-4143129-A POLYVINYLPYRROLIDONE BINDER LILLY INDUSTRIES LIMITED (GB) 1979-03-06 US claimed
US-3984403-A PAINLESS INTRAMUSCULAR INJECTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-10-05 US claimed
JP-57171994-A None JP disclosed
WO-2004014337-A2 A PROCESS FOR THE PREPARATION OF DISPERSIBLE TABLET OF CEPHALEXIN RANBAXY LABORATORIES LIMITED (IN) 2004-02-19 WO disclosed
US-5908929-A Process for the manufacture of the antibiotic 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid (cephalexin) and pharmaceutically acceptable salts thereof VITARA CHEMICALS LIMITED (IN) 1999-06-01 US disclosed
US-5908929-A Process for the manufacture of the antibiotic 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid (cephalexin) and pharmaceutically acceptable salts thereof VITARA CHEMICALS LIMITED (IN) 1999-06-01 US disclosed
US-5908929-A Process for the manufacture of the antibiotic 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid (cephalexin) and pharmaceutically acceptable salts thereof VITARA CHEMICALS LIMITED (IN) 1999-06-01 US disclosed
EP-0169995-B1 A HIGH YIELD PROCESS FOR PREPARING BETA-LACTAM ANTIBIOTICS HAVING A HIGH PURITY DEGREE IBI- Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (IT) 1993-04-14 EP disclosed
US-4684728-A Solubilizing biologically active compounds with reactive hydrogen atoms BAYER AKTIENGESELLSCHAFT (DE) 1987-08-04 US disclosed
US-4625021-A High yield process for preparing beta-lactam antibiotics having a high purity degree ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.P.A. (IT) 1986-11-25 US disclosed
US-4029806-A Nitro-β-lactam antibiotics and processes for their preparation and use BAYER AKTIENGESELLSCHAFT (DT) 1977-06-14 US disclosed
US-4025622-A ANTIBACTERIAL Ogura, Haruo (JA) 1977-05-24 US disclosed
US-4012518-A PENICILLIN DERIVATIVES AS GROWTH AND FEED UTILIZATION PROMOTERS IN ANIMALS BAYER AKTIENGESELLSCHAFT (DT) 1977-03-15 US disclosed
US-4012381-A Process for preparing cephalosporins and intermediates SOCIETA' FARMACEUTICI ITALIA S.P.A. (IT) 1977-03-15 US disclosed
US-3988326-A Process for N-acylation of 7 amino cephem compounds MEIJI SEIKA KAISHA, LTD. (JA) 1976-10-26 US disclosed
US-3984403-A PAINLESS INTRAMUSCULAR INJECTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-10-05 US disclosed
US-3972774-A BY AN ESTERASE ENZYME FROM BACILLUS ELI LILLY AND COMPANY (US) 1976-08-03 US disclosed
US-3966709-A Penicillins and cephalosporins and their production BAYER AKTIENGESELLSCHAFT (DT) 1976-06-29 US disclosed